Gracell Biotechnologies Inc. GRCL
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC 20-4586565 | Delaware | 0 | 25007900 | 0 | 0 | 25007900 | 5.2 % | 14/02/2024 |
| Rajeev Shah | Delaware | 0 | 48600300 | 0 | 48600300 | 48600300 | 9.99 % | 21/08/2023 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 48600300 | 0 | 48600300 | 48600300 | 9.99 % | 21/08/2023 |
| RA Capital Management, L.P. | Delaware | 0 | 48600300 | 0 | 48600300 | 48600300 | 9.99 % | 21/08/2023 |
| Peter Kolchinsky | Delaware | 0 | 48600300 | 0 | 48600300 | 48600300 | 9.99 % | 21/08/2023 |
| Vivo Panda Fund, L.P. | The Cayman Islands | 4806795 | 0 | 4806795 | 0 | 4806795 | 1 % | 18/08/2023 |
| Vivo Opportunity, LLC | The Cayman Islands | 38152030 | 0 | 38152030 | 0 | 38152030 | 7.8 % | 18/08/2023 |
| Vivo Asia Opportunity Fund Holdings, L.P. | The Cayman Islands | 22691515 | 0 | 22691515 | 0 | 22691515 | 4.6 % | 18/08/2023 |
| Vivo Opportunity Co-Invest, L.P. | The Cayman Islands | 12252005 | 0 | 12252005 | 0 | 12252005 | 2.5 % | 18/08/2023 |
| Opportunity Fund Holdings, L.P. | The Cayman Islands | 25900025 | 0 | 25900025 | 0 | 25900025 | 5.3 % | 18/08/2023 |
| Vivo Panda, LLC | The Cayman Islands | 4806795 | 0 | 4806795 | 0 | 4806795 | 1 % | 18/08/2023 |
| Vivo Asia Opportunity, LLC | The Cayman Islands | 22691515 | 0 | 22691515 | 0 | 22691515 | 4.6 % | 18/08/2023 |
| OrbiMed Advisors LLC | Delaware | 0 | 7583576 | 0 | 10 | 7583576 | 11.2 % | 31/03/2023 |
| OrbiMed Genesis GP LLC | Cayman Islands | 305748 | 0 | 305748 | 10 | 305748 | 0.5 % | 31/03/2023 |
| OrbiMed Advisors III Limited | Delaware | 0 | 6972080 | 0 | 10 | 6972080 | 10.3 % | 31/03/2023 |
| OrbiMed New Horizons GP LLC | Cayman Islands | 0 | 305748 | 0 | 10 | 305748 | 0.5 % | 31/03/2023 |
| OrbiMed Asia GP III, L.P. | Delaware | 0 | 6972080 | 0 | 10 | 6972080 | 10.3 % | 31/03/2023 |
| OrbiMed Capital LLC | Cayman Islands | 1914198 | 0 | 1914198 | 10 | 1914198 | 2.8 % | 31/03/2023 |
| (1) BlackRock, Inc. | Delaware | 4887820 | 0 | 4887820 | 0 | 4887820 | 7.2 % | 03/02/2023 |
| Albert Cha | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| FHMLSP, L.P. | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| Frazier Life Sciences Public Fund, L.P. | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| James Brush | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| James N. Topper | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| FHMLSP, L.L.C. | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| Patrick J. Heron | Delaware | 0 | 17104865 | 0 | 17104865 | 17104865 | 5.1 % | 17/03/2022 |
| William Wei Cao | Reporting Person | 93231540 | 0 | 93231540 | 0 | 93231540 | 26.9 % | 14/02/2022 |
| OrbiMed Asia GP III, L.P. | Delaware | 0 | 5359176 | 0 | 0 | 5359176 | 7.9 % | 11/02/2022 |
| OrbiMed Advisors LLC | Delaware | 0 | 5970672 | 0 | 0 | 5970672 | 8.9 % | 11/02/2022 |
| OrbiMed Capital LLC | Delaware | 1914198 | 0 | 1914198 | 0 | 1914198 | 2.8 % | 11/02/2022 |
| 95-1411037 | Delaware | 20318820 | 0 | 20318820 | 0 | 13 | 6 % | 11/02/2022 |
| LAV Biosciences Fund V, L.P. (“LAVV”) | 10049125 | 0 | 10049125 | 0 | 10049125 | 3.1 % | 09/02/2022 | |
| LAV Granite Limited (“GRAN”) | 14981730 | 0 | 14981730 | 0 | 14981730 | 4.6 % | 09/02/2022 | |
| Yi Shi | 0 | 25406680 | 0 | 25406680 | 25406680 | 7.8 % | 09/02/2022 | |
| LAV Biosciences Fund V sub A, L.P. (“LAVVA”) | 375825 | 0 | 375825 | 0 | 375825 | 5.6 % | 09/02/2022 | |
| Wellington Investment Advisors Holdings LLP | Delaware | 0 | 19827810 | 0 | 0 | 21460705 | 6.36 % | 04/02/2022 |
| Wellington Group Holdings LLP | Delaware | 0 | 19827810 | 0 | 0 | 21460705 | 6.36 % | 04/02/2022 |
| Wellington Management Group LLP | Massachusetts | 0 | 19827810 | 0 | 0 | 21460705 | 6.36 % | 04/02/2022 |
| Wellington Management Company LLP | Delaware | 0 | 19007915 | 0 | 0 | 19755415 | 5.85 % | 04/02/2022 |
| OrbiMed Asia GP III, L.P. | Delaware | 0 | 26795880 | 0 | 10 | 26795880 | 8.2 % | 21/01/2021 |
| OrbiMed Genesis GP LLC | Cayman Islands | 1528742 | 0 | 1528742 | 10 | 1528742 | 0.5 % | 21/01/2021 |
| OrbiMed Capital LLC | Cayman Islands | 9570993 | 0 | 9570993 | 10 | 9570993 | 2.9 % | 21/01/2021 |
| OrbiMed New Horizons GP LLC | Cayman Islands | 0 | 1528742 | 0 | 10 | 1528742 | 0.5 % | 21/01/2021 |
| OrbiMed Advisors III Limited | Delaware | 0 | 26795880 | 0 | 10 | 26795880 | 8.2 % | 21/01/2021 |
| OrbiMed Advisors LLC | Delaware | 0 | 29853364 | 0 | 10 | 29853364 | 9.1 % | 21/01/2021 |
| Fullerton Management Pte Ltd | Singapore | 0 | 49509702 | 0 | 49509702 | 49509702 | 15.1 % | 15/01/2021 |
| Temasek Holdings (Private) Limited | Singapore | 0 | 49509702 | 0 | 49509702 | 49509702 | 15.1 % | 15/01/2021 |
| Temasek Life Sciences Private Limited | Singapore | 0 | 49509702 | 0 | 49509702 | 49509702 | 15.1 % | 15/01/2021 |
| TLS Beta Pte. Ltd. | Singapore | 0 | 49509702 | 0 | 49509702 | 49509702 | 15.1 % | 15/01/2021 |